Status and phase
Conditions
Treatments
About
To determine the pharmacokinetics of single and multiple doses of FDL169 in healthy female subjects.
Full description
This is a two-part study.
Part 1:
Part 1 of the study is a single-dose, dose-escalation, study to assess the safety, tolerability and PK profiles following oral administrations of FDL169 to healthy female volunteers in the fed state. Up to five doses will be assessed.
Part 2:
Part 2 of the study is a multiple-dose study to assess the safety, tolerability and PK profiles following oral administrations of FDL169 to healthy female volunteers in the fed state.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
8 participants in 6 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal